Ostojić, A., Sertić, D., Rončević, P., Perić, Z., Granić, P., Matić, N. ... Nemet, D. (2016). Comparison of branded and generic imatinib plasma concentrations in patients with chronic myelogenous leukemia: unicentric study. Clinical Lymphoma Myeloma and Leukemia, 16. (8), 472-476. doi: 10.1016/j.clml.2016.04.003
Ostojić, Alen, et al. "Comparison of branded and generic imatinib plasma concentrations in patients with chronic myelogenous leukemia: unicentric study." Clinical Lymphoma Myeloma and Leukemia, vol. 16, no. 8, 2016, pp. 472-476. https://doi.org/10.1016/j.clml.2016.04.003
Ostojić, Alen, Dubravka Sertić, Pavle Rončević, Zinaida Perić, Paula Granić, Nikolina Matić, Sandra Bašić Kinda, et al. "Comparison of branded and generic imatinib plasma concentrations in patients with chronic myelogenous leukemia: unicentric study." Clinical Lymphoma Myeloma and Leukemia 16, no. 8 (2016): 472-476. https://doi.org/10.1016/j.clml.2016.04.003
Ostojić, A., et al. (2016) 'Comparison of branded and generic imatinib plasma concentrations in patients with chronic myelogenous leukemia: unicentric study', Clinical Lymphoma Myeloma and Leukemia, 16(8), pp. 472-476. doi: 10.1016/j.clml.2016.04.003
Ostojić A, Sertić D, Rončević P, Perić Z, Granić P, Matić N, and sur.. Comparison of branded and generic imatinib plasma concentrations in patients with chronic myelogenous leukemia: unicentric study. Clinical Lymphoma Myeloma and Leukemia [Internet]. 2016 August [cited 2024 August 18];16(8):472-476. doi: 10.1016/j.clml.2016.04.003
A. Ostojić, et al., "Comparison of branded and generic imatinib plasma concentrations in patients with chronic myelogenous leukemia: unicentric study", Clinical Lymphoma Myeloma and Leukemia, vol. 16, no. 8, pp. 472-476, August 2016. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:528120. [Accessed: 18 August 2024]